BIO/DoD Discussing Anti-Bioterrorism As Biotech Policy Priorities Shift
Executive Summary
The Biotechnology Industry Organization's recent discussions with the Department of Defense on strategies to counter bioterrorism illustrate the sudden shift in priorities in Washington, D.C. following the Sept. 11 terrorist attacks.